Literature DB >> 12001990

Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Livio Trusolino1, Paolo M Comoglio.   

Abstract

Malignant disease occurs when neoplastic cells abandon their primary site of accretion, cross tissue boundaries and penetrate the vasculature to colonize distant sites. This process --metastasis--is the aberrant counterpart of a physiological programme for organ regeneration and maintenance. Scatter factors and semaphorins, together with their receptors, help to orchestrate this programme. What are the differences between physiological and pathological activation of these signalling molecules, and can we exploit them therapeutically to prevent metastasis?

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12001990     DOI: 10.1038/nrc779

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  213 in total

1.  Metastasis movies, macrophages, molecules and more. Conference on Mechanisms of Invasion and Metastasis.

Authors:  Denise Montell
Journal:  EMBO Rep       Date:  2003-05       Impact factor: 8.807

2.  HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.

Authors:  David Liska; Chin-Tung Chen; Thomas Bachleitner-Hofmann; James G Christensen; Martin R Weiser
Journal:  Clin Cancer Res       Date:  2010-11-22       Impact factor: 12.531

3.  MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF.

Authors:  Chang-Il Hwang; Jinhyang Choi; Zongxiang Zhou; Andrea Flesken-Nikitin; Alexander Tarakhovsky; Alexander Yu Nikitin
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 4.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 5.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

6.  c-MET: an exciting new target for anticancer therapy.

Authors:  Johann S de Bono; Timothy A Yap
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

7.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

8.  Front instabilities and invasiveness of simulated avascular tumors.

Authors:  Nikodem J Popławski; Ubirajara Agero; J Scott Gens; Maciej Swat; James A Glazier; Alexander R A Anderson
Journal:  Bull Math Biol       Date:  2009-02-21       Impact factor: 1.758

9.  Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Authors:  Kyung Hee Lee; Eun Young Choi; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Heon Ju Lee; Jong Yuel Eun; Hong Gin Kim; Sung Soo Yoon; Dong Sik Lee; Jung Hye Kim; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2007-11-09       Impact factor: 5.150

10.  High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.

Authors:  Michiko Yamada; Ryuichi Tatsumi; Keitaro Yamanouchi; Tohru Hosoyama; Sei-ichi Shiratsuchi; Akiko Sato; Wataru Mizunoya; Yoshihide Ikeuchi; Mitsuhiro Furuse; Ronald E Allen
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.